Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Return on Sales (2016 - 2025)

Surgery Partners (SGRY) has disclosed Return on Sales for 12 consecutive years, with 0.03% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 9.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, up 3.0% year-over-year, with the annual reading at 0.03% for FY2025, 3.0% up from the prior year.
  • Return on Sales hit 0.03% in Q4 2025 for Surgery Partners, up from 0.03% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.09% in Q2 2023 to a low of 0.05% in Q4 2024.
  • Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.03% in 2025.
  • Biggest five-year swings in Return on Sales: decreased -12bps in 2024 and later rose 9bps in 2025.
  • Year by year, Return on Sales stood at 0.07% in 2021, then crashed by -53bps to 0.03% in 2022, then soared by 93bps to 0.06% in 2023, then crashed by -185bps to 0.05% in 2024, then surged by 161bps to 0.03% in 2025.
  • Business Quant data shows Return on Sales for SGRY at 0.03% in Q4 2025, 0.03% in Q3 2025, and 0.05% in Q2 2025.